Claritev Corp
CTEVNYSEIndustrials · Services-Business Services, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $965.4M | $930.6M | $961.5M | $1.08B | $1.12B | $937.8M |
| Operating income | $28.8M | −$1.39B | $162.0M | −$362.7M | $386.1M | −$131.8M |
| Net income | −$284.3M | −$1.65B | −$91.7M | −$572.9M | $102.1M | −$520.6M |
| Total assets | $4.89B | $5.15B | $6.96B | $7.37B | $8.22B | $8.28B |
| Total liabilities | $5.06B | $5.07B | $5.26B | $5.58B | $5.88B | $5.73B |
| Equity | −$173.9M | $84.0M | $1.71B | $1.79B | $2.34B | $2.56B |
| EPS (diluted) | $-17.30 | $-101.92 | $-5.69 | $-0.90 | $0.16 | $-1.11 |
| Shares out. | 16.2M | 644.4M | 639.2M | 638.6M | 668.9M | 655.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 3.0%
- Net margin
- −29.4%
- Return on equity
- 163.5%
- Return on assets
- −5.8%
- Return on capital (ROCE)
- 0.6%
- Liabilities / assets
- 103.4%
- Debt / equity
- —
- Book value / share
- $-10.74
- Revenue growth (YoY)
- 3.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.67distress
- Accruals / assets
- −8.2%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 2 warning● 5 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Arini Captial Management LtdPassive (13G)Feb 17, 2026
- Hellman & Friedman Investors Viii, L.P.Activist (13D)Nov 14, 2025
- Ares Management LlcPassive (13G)Feb 7, 2025
- Green Equity Investors Vi, L.P.Activist (13D)Jan 16, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Kim MichaelOfficer — EVP, Chief Digital Officer | May 18, 2026 | Buy | 3,000 | $16.65 |
| Prince John MichaelDirector | May 19, 2026 | Buy | 10,000 | $16.00 |
| Dalton TravisOfficer — Pres., CEO & Executive Chair | May 18, 2026 | Buy | 9,720 | $12.92 |
| Klapstein Julie DDirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Klein Michael StuartDirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Clarke Richard ADirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Kap Jason LamarDirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Harris C MartinDirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Prince John MichaelDirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Colaluca Anthony JrDirector | Apr 29, 2026 | Grant | 8,977 | $0.00 |
| Albinson BrockOfficer — SVP, Chief Accounting Officer | Mar 31, 2026 | Grant | 2,956 | $0.00 |
| Garis Douglas MichaelOfficer — EVP&CFO | Mar 16, 2026 | Buy | 1,300 | $17.69 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.2M | 6.7 | -2.8% |
| Apr 30, 2026 | 1.2M | 14.2 | -0.8% |
| Apr 15, 2026 | 1.2M | 15.1 | +1.7% |
| Mar 31, 2026 | 1.2M | 8.5 | -0.1% |
| Mar 13, 2026 | 1.2M | 4.9 | -7.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 18, 2026
- Results of operationsMay 7, 2026
- Director / officer change · Shareholder voteApr 30, 2026
- Regulation FD disclosureMar 16, 2026
- Results of operationsFeb 23, 2026
- Regulation FD disclosureJan 15, 2026
- Director / officer changeDec 29, 2025
- Other material eventNov 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.